drugset / Trial / NCT05534269
Stress Urinary Incontinence Study to Assess Safety and Efficacy of Muvon's Muscle Precursor Cell Therapy
RandomizedParallel-groupSingle-blindTreatment
Summary
The objective of the SUISSE MPC 2 study is to treat stress urinary incontinence in adult women.
Timeline
- Start
- 2022-10-17
- Primary completion
- 2025-07-14
- Completion
- 2025-07-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | autologous muscle precursor cells | Cell therapy | — | Intramuscular |